Search Results 131-140 of 20695 for colitis

1. A Study To Assess The Change In Disease Activity In Adult Participants With Moderate To Severe Ulcerative Colitis Treated With Risankizumab Compared To Vedolizumab - Mayo Clinic

   Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).

2. C. difficile infection - Diagnosis and treatment - Mayo Clinic

   Colitis-induced TH17 cells increase the risk for severe subsequent Clostridium difficile infection. Cell Host and Microbe. 2019;25:756. Taur Y, et al ...

3. A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis · Overview · Participation ...

4. Mayo Clinic Q and A: Treating inflammatory bowel disease

   It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...

5. Study of the Effect of SHP647 as Maintenance Treatment in Participants with Moderate to Severe Ulcerative Colitis who Achieved Clinical Response in Induction Studies - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of SHP647 as maintenance therapy in participants with moderate to severe ulcerative colitis (UC) who ...

6. Ileoanal anastomosis (J-pouch) surgery - Mayo Clinic

   This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

7. Infliximab (intravenous route) - Mayo Clinic

   Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...

8. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

9. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.

10. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...